Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(21 sites)

France

Service de Médecine Interne Infectiologie Aïgue Polyvalente- Hôpital Henri Duffaud, Avignon

Service de Pneumologie - Hôpital Avicenne, Bobigny

Service de medecine interne - Hôpital Henri Mondor, Créteil

Service de Médecine Interne et Immunologie Clinique - CHU Dijon Bourgogne, Dijon

Service de medecine interne - Hôpital Claude Huriez, Lille